Associate Director, Corporate Development

Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis’ most-advanced program, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, with multi-indication potential across multiple tumor types, including locally advanced or metastatic urothelial cancer, breast cancer, non-small cell lung cancer, colorectal cancer, cervical cancer, and head and neck cancer. Aktis’ second pipeline program, AKY-2519, is a miniprotein radioconjugate targeting B7-H3 expressing tumors, including prostate, lung and other solid tumors. Aktis has a strategic collaboration with Eli Lilly and Company to leverage its miniprotein platform to develop novel radioconjugates outside of Aktis’ proprietary pipeline.

We are seeking an Associate Director of Corporate Development. The Associate Director will lead high-impact contract negotiations, drive search and evaluation efforts, and develop actionable competitive intelligence. The ideal candidate combines a deep knowledge of the biotechnology and oncology spaces with strong analytical and communication skills. This role will work cross-functionally with R&D, CMC, G&A, and external legal counsel on a variety of initiatives. This position will report to the Executive Director of Corporate Development.

Responsibilities

This role will drive several areas of strategic importance to Aktis:

• Support Aktis leaders in establishing and maintaining relationships with industry partners and academic collaborators.
• Lead cross-functional teams through the contract lifecycle from opportunity evaluation to agreement execution.
• Search and evaluate innovative assets and technologies complementary to Aktis’ pipeline and platform.
• Lead competitive intelligence efforts to generate actionable insights for the Senior Leadership Team.
• Develop and maintain financial models and forecasts to inform strategic decisions.
• Prepare presentations, analyses, and recommendations for the Senior Leadership Team.
• Support governance committees comprised of Senior Leadership Team and other team members.

Qualifications

• Minimum of 5 years of experience either within business development at a global biopharma company or at a top-tier firm in management consulting, venture capital, or investment banking with a focus on biopharma.
• Entrepreneurial mindset with strong problem-solving and critical thinking skills.
• Demonstrated ability to build relationships with partners/collaborators and negotiate complex contracts of strategic importance.
• Demonstrated achievement in search and evaluation of assets and technologies.
• Significant experience creating and delivering presentations to senior management.
• MBA or PhD in life sciences or related field required.
• Strong desire to be part of a mission‐oriented company leading transformative change for patients.
• Proven demonstration of transparent communication and fostering open and diverse debate.
• Ability to work with agility and manage ambiguity.
• Personifies positive energy and exemplifies respect.

Knowledge, Skills and Abilities 

• Strong project management, analytical, communication and negotiation skills
• Financial modeling skills.
• Ability to lead cross-functional teams and work independently as needed
• Strong knowledge of oncology and radiopharmaceutical landscapes
• Collaborative attitude incorporating positivity and respect
• Willingness to travel to select industry conferences ~10% of time as needed

Aktis Oncology is an Equal Opportunity Employer and does not discriminate on the basis of race, religion, color, sex, gender identity or expression, sexual orientation, age, disability, national origin, veteran status, or any other basis covered by appropriate law. Aktis Oncology is committed to promoting and maintaining a work environment in which all applicants, employees, and other individuals are treated with dignity and respect free from unlawful harassment, discrimination, or retaliation.